The Role of Extracellular Vesicles in SARS-CoV-2-Induced Acute Kidney Injury: An Overview

Carter Bernal,Christiane How-Volkman,Madison Spencer,Ahmed El-Shamy,Ashraf M. Mohieldin
DOI: https://doi.org/10.3390/life14020163
2024-01-23
Life
Abstract:The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has affected millions worldwide since its outbreak in the winter of 2019. While extensive research has primarily focused on the deleterious respiratory effects of SARS-CoV-2 in recent years, its pan-tropism has become evident. Among the vital organs susceptible to SARS-CoV-2 infection is the kidney. Post SARS-CoV-2 infection, patients have developed coronavirus disease 19 (COVID-19), with reported incidences of COVID-19 patients developing acute kidney injury (AKI). Given COVID-19's multisystemic manifestation, our review focuses on the impact of SARS-CoV-2 infection within the renal system with an emphasis on the current hypotheses regarding the role of extracellular vesicles (EVs) in SARS-CoV-2 pathogenesis. Emerging studies have shown that SARS-CoV-2 can directly infect the kidney, whereas EVs are involved in the spreading of SARS-CoV-2 particles to other neighboring cells. Once the viral particles are within the kidney system, many proinflammatory signaling pathways are shown to be activated, resulting in AKI. Hence, clinical investigation of urinary proinflammatory components and total urinary extracellular vesicles (uEVs) with viral particles have been used to assess the severity of AKI in patients with COVID-19. Remarkedly, new emerging studies have shown the potential of mesenchymal stem cell-derived EVs (MSC-EVs) and ACE2-containing EVs as a hopeful therapeutic tool to inhibit SARS-CoV-2 RNA replication and block viral entry, respectively. Overall, understanding EVs' physiological role is crucial and hopefully will rejuvenate our therapeutic approach towards COVID-19 patients with AKI.
biology
What problem does this paper attempt to address?
This paper aims to explore the role of extracellular vesicles (EVs) in acute kidney injury (AKI) caused by SARS - CoV - 2. Specifically, the paper focuses on the following aspects: 1. **Mechanism of SARS - CoV - 2 infecting the kidney**: The paper describes in detail how SARS - CoV - 2 enters kidney cells through the ACE2 receptor and causes inflammatory responses and damage to kidney tissue. After the virus enters the kidney, it activates multiple pro - inflammatory signaling pathways, ultimately leading to the occurrence of AKI. 2. **Role of EVs in SARS - CoV - 2 transmission**: The study found that SARS - CoV - 2 can use EVs to transfer its virus particles to neighboring cells, thereby promoting virus spread and infection. These EVs contain the nucleocapsid protein (N protein) and spike protein (S protein) of SARS - CoV - 2 and can cause the death of healthy cells in vitro experiments. 3. **Potential of EVs as disease markers**: The paper also discusses the potential application of urinary EVs (uEVs) and their carried biomolecules (such as miRNA) in monitoring the severity of AKI and predicting disease progression. For example, the levels of certain miRNAs in uEVs are positively correlated with the severity of AKI, which provides a new approach for early diagnosis and monitoring. 4. **Treatment potential**: Finally, the paper mentions mesenchymal stem cell - derived EVs (MSC - EVs) and EVs containing ACE2 receptors as potential treatment tools for inhibiting the replication of SARS - CoV - 2 RNA and blocking virus entry. In summary, this paper mainly explores the mechanism by which SARS - CoV - 2 infection triggers AKI in the kidney through EVs, as well as the potential applications of EVs in disease diagnosis and treatment.